Lanean...
Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons
INTRODUCTION: Over the past 15 years, the discovery and development of oral medications that selectively inhibit the enzyme phosphodiesterase type 5 (PDE5) have revolutionised the treatment of erectile dysfunction (ED). Currently, three PDE5 inhibitors are widely available clinically, i.e., sildenaf...
Gorde:
| Argitaratua izan da: | Arab J Urol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4443003/ https://ncbi.nlm.nih.gov/pubmed/26558086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.aju.2013.07.009 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|